MENLO
PARK, Calif., Oct. 21,
2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a
healthcare company whose mission is to detect cancer early when it
can be cured, today announced the appointment of Sarah Krevans to its Board of Directors,
effective immediately. Ms. Krevans will also serve as a member of
the Board's Audit Committee, Compensation Committee, and Nominating
and Governance Committee. Following the appointment of Ms. Krevans,
the Board will be composed of five directors, four of whom are
independent.
Ms. Krevans served as president and CEO of Sutter Health, a
Northern California based
not-for-profit health system in one of the most diverse and
innovative regions in the nation, from 2016 to 2022. She was
responsible for Sutter Health's integrated network of 14,000
clinicians, 24 hospitals, outpatient services, research facilities,
and home health and hospice care. Under her leadership, Ms. Krevans
advanced clinical programs, innovation, and digital health to make
healthcare more accessible for patients.
"Sarah is a highly accomplished healthcare leader with extensive
experience in a dynamic and diverse environment," said Bob Ragusa, CEO of GRAIL. "I am confident that
her experience will bring immense value to GRAIL as we move toward
establishing a new standard of care for multi-cancer early
detection for patients."
Previously, Ms. Krevans served as chief operating officer, and
regional executive officer and president of the Sutter Health
Sacramento Sierra Region. She also held executive roles at Kaiser
Permanente and served as deputy director of Maine's Bureau of Medical Services and acting
director of Medicaid, health planning and licensure programs. Ms.
Krevans' experience as a board member includes serving on many
not-for-profit boards and as Chair of the California Association of
Hospitals. She currently serves on the board of the Acacium Group
and is the incoming Chair of CaringBridge.
Ms. Krevans earned master's degrees in business administration
and in public health from the University of
California, Berkeley, and a bachelor's degree from
Boston University. She has been named
as one of the "Top 25 Women Leaders" by Modern Healthcare
and included on Modern Healthcare's list of the "100 Most
Influential People in Healthcare."
About GRAIL
GRAIL is a healthcare company whose
mission is to detect cancer early, when it can be cured. GRAIL is
focused on alleviating the global burden of cancer by using the
power of next-generation sequencing, population-scale clinical
studies, and state-of-the-art machine learning, software, and
automation to detect and identify multiple deadly cancer types in
earlier stages. GRAIL's targeted methylation-based platform can
support the continuum of care for screening and precision oncology,
including multi-cancer early detection in symptomatic patients,
risk stratification, minimal residual disease detection, biomarker
subtyping, treatment and recurrence monitoring. GRAIL is
headquartered in Menlo Park, CA
with locations in Washington,
D.C., North Carolina, and
the United Kingdom.
For more information, visit grail.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/grail-appoints-sarah-krevans-to-board-of-directors-302282199.html
SOURCE GRAIL, Inc.